首页|万古霉素两种给药途径辅助持续引流治疗脑外伤继发颅内感染的临床研究

万古霉素两种给药途径辅助持续引流治疗脑外伤继发颅内感染的临床研究

扫码查看
目的 探讨万古霉素经鞘内注射、静脉滴注辅助持续引流治疗脑外伤继发颅内感染的临床应用效果.方法 选取2015年12月~2017年3月天津市宝坻区人民医院收治的96例脑外伤继发颅内感染患者,经单双数字法(入院就诊顺序)随机均分为研究组和对照组,每组48例.研究组患者给予持续引流联合万古霉素鞘内注射治疗,对照组患者给予持续引流联合万古霉素静脉滴注.记录比较2组患者的临床疗效.结果 治疗后,研究组临床治疗总有效率为89.58%,对照组为70.83%,2组比较差异具有统计学意义(P<0.05).结论应用万古霉素鞘内注射联合持续引流治疗脑外伤继发颅内感染疗效更优,有利于保障患者生活质量、生命安全.
Clinical study of two routes of vancomycin assisted continuous drainage in the treatment of secondary intracranial infection after traumatic brain injury
Objective To investigate the clinical effect of continuous infusion of vancomycin in the treatment of intracranial infection secondary to traumatic brain injury by intrathecal injection and intravenous infusion. Methods 96 patients with traumatic brain injury from December 2015 to March 2017 were randomly divided into study group and control group, the patients were randomly divided into study group and control group (n=48).The study group of patients with continuous drainage combined with vancomycin intrathecal injection treatment, the control group of patients with continuous drainage combined with vancomycin intravenous infusion. The clinical effects of two groups of patients with secondary intracranial infection after traumatic brain injury were recorded. Results After treatment, the total effective rate of clinical treatment in the study group was as high as 89.58%, compared with 70.83% in the control group, the differences were statistically significant(P<0.05). Conclusion Vancomycin intrathecal injection combined with continuous drainage is effective in the treatment of secondary intracranial infection after brain injury, and it is beneficial to protect the quality of life and life safety of the patients.

traumatic brain injury secondary intracranial infectionvancomycinintrathecal injectionintravenous dripcontinuous drainageapplication effect

郭志刚、张克利

展开 >

天津市宝坻区人民医院,天津医科大学宝坻临床学院 神经外科,天津 301800

脑外伤继发颅内感染 万古霉素 鞘内注射 静脉滴注 持续引流

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(10)
  • 1
  • 5